{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:16:38Z","timestamp":1790471798690,"version":"4.1.0"},"publisher-location":"Cham","reference-count":146,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319658513","type":"print"},{"value":"9783319658537","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/164_2017_15","type":"book-chapter","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T14:23:06Z","timestamp":1488982986000},"page":"81-108","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Sigma-1 (\u03c31) Receptor in Memory and Neurodegenerative Diseases"],"prefix":"10.1007","author":[{"given":"Tangui","family":"Maurice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Goguadze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"issue":"2","key":"15_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0959-4388(95)80021-2","volume":"5","author":"TG Aigner","year":"1995","unstructured":"Aigner TG (1995) Pharmacology of memory: cholinergic-glutamatergic interactions. Curr Opin Neurobiol 5(2):155\u2013160","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"15_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0306-4522(00)00014-2","volume":"97","author":"G Alonso","year":"2000","unstructured":"Alonso G, Phan V, Guillemain I, Saunier M, Legrand A, Anoal M, Maurice T (2000) Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 97(1):155\u2013170","journal-title":"Neuroscience"},{"issue":"6","key":"15_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/ana.22534","volume":"70","author":"A Al-Saif","year":"2011","unstructured":"Al-Saif A, Al-Mohanna F, Bohlega S (2011) A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol 70(6):913\u2013919. doi: 10.1002\/ana.22534","journal-title":"Ann Neurol"},{"issue":"4","key":"15_CR4","first-page":"513","volume":"58","author":"HF Aly","year":"2011","unstructured":"Aly HF, Metwally FM, Ahmed HH (2011) Neuroprotective effects of dehydroepiandrosterone (DHEA) in rat model of Alzheimer's disease. Acta Biochim Pol 58(4):513\u2013520","journal-title":"Acta Biochim Pol"},{"issue":"3","key":"15_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/jad-2011-101794","volume":"24","author":"V Antonini","year":"2011","unstructured":"Antonini V, Marrazzo A, Kleiner G, Coradazzi M, Ronsisvalle S, Prezzavento O, Ronsisvalle G, Leanza G (2011) Anti-amnesic and neuroprotective actions of the sigma-1 receptor agonist (\u2212)-MR22 in rats with selective cholinergic lesion and amyloid infusion. J Alzheimers Dis 24(3):569\u2013586. doi: 10.3233\/jad-2011-101794","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"15_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1124\/jpet.113.208348","volume":"347","author":"AA Behensky","year":"2013","unstructured":"Behensky AA, Yasny IE, Shuster AM, Seredenin SB, Petrov AV, Cuevas J (2013) Stimulation of sigma receptors with afobazole blocks activation of microglia and reduces toxicity caused by amyloid-beta25-35. J Pharmacol Exp Ther 347(2):458\u2013467. doi: 10.1124\/jpet.113.208348","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 2","key":"15_CR7","doi-asserted-by":"publisher","first-page":"Ii3","DOI":"10.1007\/pl00007758","volume":"247","author":"H Braak","year":"2000","unstructured":"Braak H, Braak E (2000) Pathoanatomy of Parkinson\u2019s disease. J Neurol 247(Suppl 2):Ii3\u2013I10. doi: 10.1007\/pl00007758","journal-title":"J Neurol"},{"issue":"1","key":"15_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318(1):121\u2013134. doi: 10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"issue":"1","key":"15_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20150934","volume":"473","author":"GC Brailoiu","year":"2016","unstructured":"Brailoiu GC, Deliu E, Console-Bram LM, Soboloff J, Abood ME, Unterwald EM, Brailoiu E (2016) Cocaine inhibits store-operated Ca2+ entry in brain microvascular endothelial cells: critical role for sigma-1 receptors. Biochem J 473(1):1\u20135. doi: 10.1042\/bj20150934","journal-title":"Biochem J"},{"issue":"1","key":"15_CR10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1083\/jcb.200407024","volume":"168","author":"J Cao","year":"2005","unstructured":"Cao J, Viholainen JI, Dart C, Warwick HK, Leyland ML, Courtney MJ (2005) The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J Cell Biol 168(1):117\u2013126. doi: 10.1083\/jcb.200407024","journal-title":"J Cell Biol"},{"issue":"18","key":"15_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2174\/092986710791163939","volume":"17","author":"BC Cheah","year":"2010","unstructured":"Cheah BC, Vucic S, Krishnan AV, Kiernan MC (2010) Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 17(18):1199\u20131942","journal-title":"Curr Med Chem"},{"issue":"3","key":"15_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.neuropharm.2006.05.011","volume":"51","author":"L Chen","year":"2006","unstructured":"Chen L, Miyamoto Y, Furuya K, Dai XN, Mori N, Sokabe M (2006) Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplification of Src-dependent NMDA receptor signaling. Neuropharmacology 51(3):659\u2013670. doi: 10.1016\/j.neuropharm.2006.05.011","journal-title":"Neuropharmacology"},{"issue":"7","key":"15_CR13","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1177\/0269881111400648","volume":"25","author":"N Chevallier","year":"2011","unstructured":"Chevallier N, Keller E, Maurice T (2011) Behavioural phenotyping of knockout mice for the sigma-1 (sigma(1)) chaperone protein revealed gender-related anxiety, depressive-like and memory alterations. J Psychopharmacol 25(7):960\u2013975. doi: 10.1177\/0269881111400648","journal-title":"J Psychopharmacol"},{"issue":"9648","key":"15_CR14","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502\u20131517. doi: 10.1016\/s0140-6736(08)61620-7","journal-title":"Lancet"},{"issue":"6","key":"15_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau de","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535. doi: 10.1016\/s1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"issue":"1","key":"15_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","volume":"62","author":"MC Rijk de","year":"1997","unstructured":"de Rijk MC, Tzourio C, Breteler MM, Dartigues JF, Amaducci L, Lopez-Pousa S, Manubens-Bertran JM, Alperovitch A, Rocca WA (1997) Prevalence of parkinsonism and Parkinson\u2019s disease in Europe: the EUROPARKINSON collaborative study. European Community Concerted Action on the epidemiology of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62(1):10\u201315","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"15_CR17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/jamaneurol.2013.4408","volume":"70","author":"ER Dorsey","year":"2013","unstructured":"Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AF, Biglan KM, Shoulson I (2013) Natural history of Huntington disease. JAMA Neurol 70(12):1520\u20131530. doi: 10.1001\/jamaneurol.2013.4408","journal-title":"JAMA Neurol"},{"issue":"2","key":"15_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/sj.bjp.0707386","volume":"152","author":"J Espallergues","year":"2007","unstructured":"Espallergues J, Lapalud P, Christopoulos A, Avlani VA, Sexton PM, Vamvakides A, Maurice T (2007) Involvement of the sigma1 (sigma1) receptor in the anti-amnesic, but not antidepressant-like, effects of the aminotetrahydrofuran derivative ANAVEX1-41. Br J Pharmacol 152(2):267\u2013279. doi: 10.1038\/sj.bjp.0707386","journal-title":"Br J Pharmacol"},{"issue":"2","key":"15_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neulet.2012.04.046","volume":"517","author":"A Feher","year":"2012","unstructured":"Feher A, Juhasz A, Laszlo A, Kalman J Jr, Pakaski M, Kalman J, Janka Z (2012) Association between a variant of the sigma-1 receptor gene and Alzheimer's disease. Neurosci Lett 517(2):136\u2013139. doi: 10.1016\/j.neulet.2012.04.046","journal-title":"Neurosci Lett"},{"issue":"12","key":"15_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S1474-4422(11)70247-2","volume":"10","author":"A Feigin","year":"2011","unstructured":"Feigin A (2011) Pridopidine in treatment of Huntington\u2019s disease: beyond chorea? Lancet Neurol 10(12):1036\u20131037. doi: 10.1016\/s1474-4422(11)70247-2","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"15_CR21","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000440864","volume":"16","author":"A Fisher","year":"2016","unstructured":"Fisher A, Bezprozvanny I, Wu L, Ryskamp DA, Bar-Ner N, Natan N, Brandeis R, Elkon H, Nahum V, Gershonov E, LaFerla FM, Medeiros R (2016) AF710B, a novel M1\/sigma1 agonist with therapeutic efficacy in animal models of Alzheimer\u2019s disease. Neurodegener Dis 16(1\u20132):95\u2013110. doi: 10.1159\/000440864","journal-title":"Neurodegener Dis"},{"issue":"5916","key":"15_CR22","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1126\/science.1166127","volume":"323","author":"D Fontanilla","year":"2009","unstructured":"Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 323(5916):934\u2013937","journal-title":"Science"},{"issue":"2","key":"15_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/ageing\/afh013","volume":"33","author":"RB Forbes","year":"2004","unstructured":"Forbes RB, Colville S, Swingler RJ (2004) The epidemiology of amyotrophic lateral sclerosis (ALS\/MND) in people aged 80 or over. Age Ageing 33(2):131\u2013134. doi: 10.1093\/ageing\/afh013","journal-title":"Age Ageing"},{"issue":"2","key":"15_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1152\/physrev.00035.2006","volume":"87","author":"JK Foskett","year":"2007","unstructured":"Foskett JK, White C, Cheung KH, Mak DO (2007) Inositol trisphosphate receptor Ca2+ release channels. Physiol Rev 87(2):593\u2013658. doi: 10.1152\/physrev.00035.2006","journal-title":"Physiol Rev"},{"issue":"Pt 7","key":"15_CR25","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/brain\/awu107","volume":"137","author":"V Francardo","year":"2014","unstructured":"Francardo V, Bez F, Wieloch T, Nissbrandt H, Ruscher K, Cenci MA (2014) Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain 137(Pt 7):1998\u20132014. doi: 10.1093\/brain\/awu107","journal-title":"Brain"},{"issue":"3\u20134","key":"15_CR26","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0014-2999(84)90404-7","volume":"104","author":"AS Freeman","year":"1984","unstructured":"Freeman AS, Bunney BS (1984) The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur J Pharmacol 104(3\u20134):287\u2013293","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"15_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0006-8993(80)80031-X","volume":"202","author":"S Fujimoto","year":"1980","unstructured":"Fujimoto S, Yamamoto K, Kuba K, Morita K, Kato E (1980) Calcium localization in the sympathetic ganglion of the bullfrog and effects of caffeine. Brain Res 202(1):21\u201332","journal-title":"Brain Res"},{"issue":"11","key":"15_CR28","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","volume":"27","author":"JM Gil","year":"2008","unstructured":"Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington's disease. Eur J Neurosci 27(11):2803\u20132820. doi: 10.1111\/j.1460-9568.2008.06310.x","journal-title":"Eur J Neurosci"},{"issue":"Pt 8","key":"15_CR29","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/awl075","volume":"129","author":"R Gold","year":"2006","unstructured":"Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129(Pt 8):1953\u20131971. doi: 10.1093\/brain\/awl075","journal-title":"Brain"},{"issue":"2","key":"15_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ceca.2009.12.002","volume":"47","author":"J Grosskreutz","year":"2010","unstructured":"Grosskreutz J, Van Den Bosch L, Keller BU (2010) Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47(2):165\u2013174. doi: 10.1016\/j.ceca.2009.12.002","journal-title":"Cell Calcium"},{"issue":"1","key":"15_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuroscience.2009.03.067","volume":"162","author":"MS Guzman-Lenis","year":"2009","unstructured":"Guzman-Lenis MS, Navarro X, Casas C (2009) Selective sigma receptor agonist 2-(4-morpholinethyl)1-phenylcyclohexanecarboxylate (PRE084) promotes neuroprotection and neurite elongation through protein kinase C (PKC) signaling on motoneurons. Neuroscience 162(1):31\u201338. doi: 10.1016\/j.neuroscience.2009.03.067","journal-title":"Neuroscience"},{"issue":"5","key":"15_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.molmed.2013.03.004","volume":"19","author":"A Haghikia","year":"2013","unstructured":"Haghikia A, Hohlfeld R, Gold R, Fugger L (2013) Therapies for multiple sclerosis: translational achievements and outstanding needs. Trends Mol Med 19(5):309\u2013319. doi: 10.1016\/j.molmed.2013.03.004","journal-title":"Trends Mol Med"},{"issue":"15","key":"15_CR33","doi-asserted-by":"publisher","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","volume":"93","author":"M Hanner","year":"1996","unstructured":"Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H (1996) Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A 93(15):8072\u20138077","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"15_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","volume":"7","author":"O Hardiman","year":"2011","unstructured":"Hardiman O, van den Berg LH, Kiernan MC (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 7(11):639\u2013649. doi: 10.1038\/nrneurol.2011.153","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"15_CR35","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3565(24)39299-7","volume":"293","author":"T Hayashi","year":"2000","unstructured":"Hayashi T, Maurice T, Su TP (2000) Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration. J Pharmacol Exp Ther 293(3):788\u2013798","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"15_CR36","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1124\/jpet.103.051284","volume":"306","author":"T Hayashi","year":"2003","unstructured":"Hayashi T, Su TP (2003) Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J Pharmacol Exp Ther 306(2):718\u2013725","journal-title":"J Pharmacol Exp Ther"},{"issue":"41","key":"15_CR37","doi-asserted-by":"publisher","first-page":"14949","DOI":"10.1073\/pnas.0402890101","volume":"101","author":"T Hayashi","year":"2004","unstructured":"Hayashi T, Su TP (2004) Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation. Proc Natl Acad Sci U S A 101(41):14949\u201314954","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"15_CR38","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.lfs.2005.05.009","volume":"77","author":"T Hayashi","year":"2005","unstructured":"Hayashi T, Su TP (2005) The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse. Life Sci 77(14):1612\u20131624","journal-title":"Life Sci"},{"issue":"3","key":"15_CR39","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","volume":"131","author":"T Hayashi","year":"2007","unstructured":"Hayashi T, Su TP (2007) Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 131(3):596\u2013610","journal-title":"Cell"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-90-481-8622-8_13","volume":"51","author":"T Hayashi","year":"2010","unstructured":"Hayashi T, Su TP (2010) Cholesterol at the endoplasmic reticulum: roles of the sigma-1 receptor chaperone and implications thereof in human diseases. Subcell Biochem 51:381\u2013398. doi: 10.1007\/978-90-481-8622-8_13","journal-title":"Subcell Biochem"},{"issue":"7","key":"15_CR41","doi-asserted-by":"publisher","first-page":"e41303","DOI":"10.1371\/journal.pone.0041303","volume":"7","author":"YL He","year":"2012","unstructured":"He YL, Zhang CL, Gao XF, Yao JJ, Hu CL, Mei YA (2012) Cyproheptadine enhances the I(K) of mouse cortical neurons through sigma-1 receptor-mediated intracellular signal pathway. PLoS One 7(7):e41303. doi: 10.1371\/journal.pone.0041303","journal-title":"PLoS One"},{"issue":"2 pt 1","key":"15_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1083\/jcb.70.2.338","volume":"70","author":"M Henkart","year":"1976","unstructured":"Henkart M, Landis DM, Reese TS (1976) Similarity of junctions between plasma membranes and endoplasmic reticulum in muscle and neurons. J Cell Biol 70(2 pt 1):338\u2013347","journal-title":"J Cell Biol"},{"issue":"3","key":"15_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1474-4422(15)00313-0","volume":"15","author":"R Hohlfeld","year":"2016","unstructured":"Hohlfeld R, Dornmair K, Meinl E, Wekerle H (2016) The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research. Lancet Neurol 15(3):317\u2013331. doi: 10.1016\/s1474-4422(15)00313-0","journal-title":"Lancet Neurol"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"e1832","DOI":"10.1038\/cddis.2015.194","volume":"6","author":"J Hong","year":"2015","unstructured":"Hong J, Sha S, Zhou L, Wang C, Yin J, Chen L (2015) Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons. Cell Death Dis 6:e1832. doi: 10.1038\/cddis.2015.194","journal-title":"Cell Death Dis"},{"issue":"1","key":"15_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/syn.10107","volume":"46","author":"B Horan","year":"2002","unstructured":"Horan B, Gifford AN, Matsuno K, Mita S, Ashby CR Jr (2002) Effect of SA4503 on the electrically evoked release of (3)H-acetylcholine from striatal and hippocampal rat brain slices. Synapse 46(1):1\u20133. doi: 10.1002\/syn.10107","journal-title":"Synapse"},{"issue":"7","key":"15_CR46","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2174\/156720511797633232","volume":"8","author":"Y Huang","year":"2011","unstructured":"Huang Y, Zheng L, Halliday G, Dobson-Stone C, Wang Y, Tang HD, Cao L, Deng YL, Wang G, Zhang YM, Wang JH, Hallupp M, Kwok J, Chen SD (2011) Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer\u2019s disease. Curr Alzheimer Res 8(7):765\u2013770","journal-title":"Curr Alzheimer Res"},{"key":"15_CR47","first-page":"317","volume":"26","author":"G Huntington","year":"1872","unstructured":"Huntington G (1872) On chorea. Med Surg Reporter 26:317\u2013321","journal-title":"Med Surg Reporter"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1038\/cddis.2013.170","volume":"4","author":"A Hyrskyluoto","year":"2013","unstructured":"Hyrskyluoto A, Pulli I, Tornqvist K, Ho TH, Korhonen L, Lindholm D (2013) Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-kappaB pathway. Cell Death Dis 4:e646. doi: 10.1038\/cddis.2013.170","journal-title":"Cell Death Dis"},{"issue":"2","key":"15_CR49","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0006-8993(93)91441-T","volume":"623","author":"KL Jansen","year":"1993","unstructured":"Jansen KL, Faull RL, Storey P, Leslie RA (1993) Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer\u2019s disease correlates with CA1 pyramidal cell loss. Brain Res 623(2):299\u2013302","journal-title":"Brain Res"},{"issue":"2\u20133","key":"15_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0014-2999(91)90593-F","volume":"200","author":"JL Junien","year":"1991","unstructured":"Junien JL, Roman FJ, Brunelle G, Pascaud X (1991) JO1784, a novel sigma ligand, potentiates [3H]acetylcholine release from rat hippocampal slices. Eur J Pharmacol 200(2\u20133):343\u2013345","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"15_CR51","doi-asserted-by":"publisher","first-page":"e1957","DOI":"10.1016\/j.neurobiolaging.2014.03.001","volume":"35","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, Kwon MJ, Choi WJ, Oh KW, Oh SI, Ki CS, Kim SH (2014) Mutations in UBQLN2 and SIGMAR1 genes are rare in Korean patients with amyotrophic lateral sclerosis. Neurobiol Aging 35(8):e1957\u2013e1958. doi: 10.1016\/j.neurobiolaging.2014.03.001","journal-title":"Neurobiol Aging"},{"issue":"7","key":"15_CR52","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.neuropharm.2010.02.013","volume":"58","author":"T Kishi","year":"2010","unstructured":"Kishi T, Yoshimura R, Okochi T, Fukuo Y, Kitajima T, Okumura T, Tsunoka T, Kawashima K, Yamanouchi Y, Kinoshita Y, Umene-Nakano W, Naitoh H, Nakamura J, Ozaki N, Iwata N (2010) Association analysis of SIGMAR1 with major depressive disorder and SSRI response. Neuropharmacology 58(7):1168\u20131173. doi: 10.1016\/j.neuropharm.2010.02.013","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"15_CR53","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cell.2012.12.004","volume":"152","author":"S Kourrich","year":"2013","unstructured":"Kourrich S, Hayashi T, Chuang JY, Tsai SY, Su TP, Bonci A (2013) Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine. Cell 152(1\u20132):236\u2013247. doi: 10.1016\/j.cell.2012.12.004","journal-title":"Cell"},{"issue":"9","key":"15_CR54","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/npp.2013.70","volume":"38","author":"V Lahmy","year":"2013","unstructured":"Lahmy V, Meunier J, Malmstrom S, Naert G, Givalois L, Kim SH, Villard V, Vamvakides A, Maurice T (2013) Blockade of Tau hyperphosphorylation and Abeta(1)(\u2212)(4)(2) generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and sigma(1) receptor agonist, in a nontransgenic mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 38(9):1706\u20131723. doi: 10.1038\/npp.2013.70","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"15_CR55","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/NEN.0b013e31816fc975","volume":"67","author":"R Lande","year":"2008","unstructured":"Lande R, Gafa V, Serafini B, Giacomini E, Visconti A, Remoli ME, Severa M, Parmentier M, Ristori G, Salvetti M, Aloisi F, Coccia EM (2008) Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J Neuropathol Exp Neurol 67(5):388\u2013401. doi: 10.1097\/NEN.0b013e31816fc975","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"15_CR56","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-3565(25)24925-4","volume":"238","author":"BL Largent","year":"1986","unstructured":"Largent BL, Gundlach AL, Snyder SH (1986a) Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J Pharmacol Exp Ther 238(2):739\u2013748","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"15_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0014-2999(86)90142-1","volume":"124","author":"BL Largent","year":"1986","unstructured":"Largent BL, Gundlach AL, Snyder SH (1986b) Sigma receptors on NCB-20 hybrid neurotumor cells labeled with (+)[3H]SKF 10,047 and (+)[3H]3-PPP. Eur J Pharmacol 124(1\u20132):183\u2013187","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"15_CR58","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1523\/JNEUROSCI.21-05-01569.2001","volume":"21","author":"BS Li","year":"2001","unstructured":"Li BS, Ma W, Zhang L, Barker JL, Stenger DA, Pant HC (2001) Activation of phosphatidylinositol-3 kinase (PI-3K) and extracellular regulated kinases (Erk1\/2) is involved in muscarinic receptor-mediated DNA synthesis in neural progenitor cells. J Neurosci 21(5):1569\u20131579","journal-title":"J Neurosci"},{"issue":"5","key":"15_CR59","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.neuropharm.2006.06.007","volume":"51","author":"Z Li","year":"2006","unstructured":"Li Z, Zhou R, Cui S, Xie G, Cai W, Sokabe M, Chen L (2006) Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor. Neuropharmacology 51(5):958\u2013966. doi: 10.1016\/j.neuropharm.2006.06.007","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"15_CR60","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/0006-8993(95)00049-V","volume":"675","author":"BP Lockhart","year":"1995","unstructured":"Lockhart BP, Soulard P, Benicourt C, Privat A, Junien JL (1995) Distinct neuroprotective profiles for sigma ligands against N-methyl-D-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res 675(1\u20132):110\u2013120","journal-title":"Brain Res"},{"issue":"4","key":"15_CR61","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","volume":"81","author":"G Logroscino","year":"2010","unstructured":"Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E (2010) Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81(4):385\u2013390. doi: 10.1136\/jnnp.2009.183525","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"15_CR62","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ana.22274","volume":"68","author":"AA Luty","year":"2010","unstructured":"Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlstrom H, Sobow T, Tchorzewska J, Maruszak A, Barcikowska M, Panegyres PK, Zekanowski C, Brooks WS, Williams KL, Blair IP, Mather KA, Sachdev PS, Halliday GM, Schofield PR (2010) Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol 68(5):639\u2013649. doi: 10.1002\/ana.22274","journal-title":"Ann Neurol"},{"issue":"10","key":"15_CR63","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1111\/bph.13076","volume":"172","author":"M Malik","year":"2015","unstructured":"Malik M, Rangel-Barajas C, Sumien N, Su C, Singh M, Chen Z, Huang RQ, Meunier J, Maurice T, Mach RH, Luedtke RR (2015) The effects of sigma (sigma1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice. Br J Pharmacol 172(10):2519\u20132531. doi: 10.1111\/bph.13076","journal-title":"Br J Pharmacol"},{"issue":"4","key":"15_CR64","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s13311-012-0140-y","volume":"9","author":"R Mancuso","year":"2012","unstructured":"Mancuso R, Olivan S, Rando A, Casas C, Osta R, Navarro X (2012) Sigma-1R agonist improves motor function and motoneuron survival in ALS mice. Neurotherapeutics 9(4):814\u2013826. doi: 10.1007\/s13311-012-0140-y","journal-title":"Neurotherapeutics"},{"issue":"11","key":"15_CR65","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/00001756-200508010-00018","volume":"16","author":"A Marrazzo","year":"2005","unstructured":"Marrazzo A, Caraci F, Salinaro ET, Su TP, Copani A, Ronsisvalle G (2005) Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity. Neuroreport 16(11):1223\u20131226","journal-title":"Neuroreport"},{"issue":"3","key":"15_CR66","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","volume":"197","author":"WR Martin","year":"1976","unstructured":"Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197(3):517\u2013532","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 1","key":"15_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1113\/jphysiol.2006.116178","volume":"578","author":"M Martina","year":"2007","unstructured":"Martina M, Turcotte ME, Halman S, Bergeron R (2007) The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus. J Physiol 578(Pt 1):143\u2013157","journal-title":"J Physiol"},{"issue":"6","key":"15_CR68","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000101990","volume":"23","author":"A Maruszak","year":"2007","unstructured":"Maruszak A, Safranow K, Gacia M, Gabryelewicz T, Slowik A, Styczynska M, Peplonska B, Golan MP, Zekanowski C, Barcikowska M (2007) Sigma receptor type 1 gene variation in a group of Polish patients with Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 23(6):432\u2013438. doi: 10.1159\/000101990","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"15_CR69","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0022-3565(25)38212-1","volume":"265","author":"K Matsuno","year":"1993","unstructured":"Matsuno K, Matsunaga K, Senda T, Mita S (1993) Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J Pharmacol Exp Ther 265(2):851\u2013859","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"15_CR70","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0006-8993(95)00618-Z","volume":"690","author":"K Matsuno","year":"1995","unstructured":"Matsuno K, Senda T, Kobayashi T, Mita S (1995) Involvement of sigma 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats. Brain Res 690(2):200\u2013206","journal-title":"Brain Res"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbr.2015.09.020","volume":"296","author":"T Maurice","year":"2016","unstructured":"Maurice T (2016) Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments. Behav Brain Res 296:270\u2013278. doi: 10.1016\/j.bbr.2015.09.020","journal-title":"Behav Brain Res"},{"key":"15_CR72","unstructured":"Maurice T, Lahmy V, Strehaiano M, Dekeuwer A, Naert G, Desrumeaux C, Villard V, Chevallier N (2015) Genetic invalidation or pharmacological activation of the sigma-1 chaperone protein modulates toxicity in the transgenic hAPPSwe mouse line. French Soc Neurosci Abstr"},{"issue":"4","key":"15_CR73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0149-7634(02)00017-9","volume":"26","author":"T Maurice","year":"2002","unstructured":"Maurice T, Martin-Fardon R, Romieu P, Matsumoto RR (2002) Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev 26(4):499\u2013527","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"15_CR74","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0006-8993(96)00565-3","volume":"733","author":"T Maurice","year":"1996","unstructured":"Maurice T, Roman FJ, Su TP, Privat A (1996) Beneficial effects of sigma agonists on the age-related learning impairment in the senescence-accelerated mouse (SAM). Brain Res 733(2):219\u2013230","journal-title":"Brain Res"},{"issue":"Suppl 3","key":"15_CR75","doi-asserted-by":"publisher","first-page":"S198","DOI":"10.1055\/s-2004-832678","volume":"37","author":"T Maurice","year":"2004","unstructured":"Maurice T, Romieu P (2004) Involvement of the sigma1 receptor in the appetitive effects of cocaine. Pharmacopsychiatry 37(Suppl 3):S198\u2013S207. doi: 10.1055\/s-2004-832678","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"15_CR76","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","volume":"124","author":"T Maurice","year":"2009","unstructured":"Maurice T, Su TP (2009) The pharmacology of sigma-1 receptors. Pharmacol Ther 124(2):195\u2013206","journal-title":"Pharmacol Ther"},{"issue":"2","key":"15_CR77","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0306-4522(97)00405-3","volume":"83","author":"T Maurice","year":"1998","unstructured":"Maurice T, Su TP, Privat A (1998) Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 83(2):413\u2013428","journal-title":"Neuroscience"},{"key":"15_CR78","unstructured":"Maurice T, Villard V, Duhr F, Chevallier N (2010) Amyloid toxicity induced by in vivo injection of A\u03b22535 oligomeric preparations is enhanced after pharmacologic or genetic invalidation of the sigma-1 chaperone protein. Soc Neurosci Abstr Program No 2477 San Diego, CA"},{"issue":"2","key":"15_CR79","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neuroscience.2010.02.022","volume":"167","author":"TA Mavlyutov","year":"2010","unstructured":"Mavlyutov TA, Epstein ML, Andersen KA, Ziskind-Conhaim L, Ruoho AE (2010) The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 167(2):247\u2013255. doi: 10.1016\/j.neuroscience.2010.02.022","journal-title":"Neuroscience"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuroscience.2013.02.035","volume":"240","author":"TA Mavlyutov","year":"2013","unstructured":"Mavlyutov TA, Epstein ML, Verbny YI, Huerta MS, Zaitoun I, Ziskind-Conhaim L, Ruoho AE (2013) Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience 240:129\u2013134. doi: 10.1016\/j.neuroscience.2013.02.035","journal-title":"Neuroscience"},{"key":"15_CR81","first-page":"1034","volume":"17","author":"TA Mavlyutov","year":"2011","unstructured":"Mavlyutov TA, Nickells RW, Guo LW (2011) Accelerated retinal ganglion cell death in mice deficient in the sigma-1 receptor. Mol Vis 17:1034\u20131043","journal-title":"Mol Vis"},{"issue":"2","key":"15_CR82","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3565(25)24688-2","volume":"257","author":"DJ McCann","year":"1991","unstructured":"McCann DJ, Su TP (1991) Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes. J Pharmacol Exp Ther 257(2):547\u2013554","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"15_CR83","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1017\/S1461145713000928","volume":"16","author":"HY Meltzer","year":"2013","unstructured":"Meltzer HY, Rajagopal L, Huang M, Oyamada Y, Kwon S, Horiguchi M (2013) Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia. Int J Neuropsychopharmacol 16(10):2181\u20132194. doi: 10.1017\/s1461145713000928","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"15_CR84","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1124\/jpet.109.160960","volume":"332","author":"J Meunier","year":"2010","unstructured":"Meunier J, Hayashi T (2010) Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB. J Pharmacol Exp Ther 332(2):388\u2013397. doi: 10.1124\/jpet.109.160960","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"15_CR85","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/sj.bjp.0706927","volume":"149","author":"J Meunier","year":"2006","unstructured":"Meunier J, Ieni J, Maurice T (2006) The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol 149(8):998\u20131012. doi: 10.1038\/sj.bjp.0706927","journal-title":"Br J Pharmacol"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.nbd.2014.11.005","volume":"74","author":"Y Miki","year":"2015","unstructured":"Miki Y, Tanji K, Mori F, Wakabayashi K (2015) Sigma-1 receptor is involved in degradation of intranuclear inclusions in a cellular model of Huntington\u2019s disease. Neurobiol Dis 74:25\u201331. doi: 10.1016\/j.nbd.2014.11.005","journal-title":"Neurobiol Dis"},{"issue":"2","key":"15_CR87","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-0404.2005.00432.x","volume":"112","author":"M Mishina","year":"2005","unstructured":"Mishina M, Ishiwata K, Ishii K, Kitamura S, Kimura Y, Kawamura K, Oda K, Sasaki T, Sakayori O, Hamamoto M, Kobayashi S, Katayama Y (2005) Function of sigma1 receptors in Parkinson\u2019s disease. Acta Neurol Scand 112(2):103\u2013107. doi: 10.1111\/j.1600-0404.2005.00432.x","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"15_CR88","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12149-007-0094-z","volume":"22","author":"M Mishina","year":"2008","unstructured":"Mishina M, Ohyama M, Ishii K, Kitamura S, Kimura Y, Oda K, Kawamura K, Sasaki T, Kobayashi S, Katayama Y, Ishiwata K (2008) Low density of sigma1 receptors in early Alzheimer\u2019s disease. Ann Nucl Med 22(3):151\u2013156. doi: 10.1007\/s12149-007-0094-z","journal-title":"Ann Nucl Med"},{"issue":"1","key":"15_CR89","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.biopsych.2003.07.008","volume":"55","author":"R Miyatake","year":"2004","unstructured":"Miyatake R, Furukawa A, Matsushita S, Higuchi S, Suwaki H (2004) Functional polymorphisms in the sigma1 receptor gene associated with alcoholism. Biol Psychiatry 55(1):85\u201390","journal-title":"Biol Psychiatry"},{"issue":"1","key":"15_CR90","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/BF00167567","volume":"346","author":"FP Monnet","year":"1992","unstructured":"Monnet FP, Blier P, Debonnel G, de Montigny C (1992a) Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency. Naunyn Schmiedebergs Arch Pharmacol 346(1):32\u201339","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"15_CR91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3565(25)10951-8","volume":"261","author":"FP Monnet","year":"1992","unstructured":"Monnet FP, Debonnel G, de Montigny C (1992b) In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. J Pharmacol Exp Ther 261(1):123\u2013130","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"15_CR92","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0014-2999(90)90186-A","volume":"179","author":"FP Monnet","year":"1990","unstructured":"Monnet FP, Debonnel G, Junien JL, De Montigny C (1990) N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors. Eur J Pharmacol 179(3):441\u2013445","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"15_CR93","doi-asserted-by":"publisher","first-page":"3774","DOI":"10.1073\/pnas.92.9.3774","volume":"92","author":"FP Monnet","year":"1995","unstructured":"Monnet FP, Mahe V, Robel P, Baulieu EE (1995) Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A 92(9):3774\u20133778","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"15_CR94","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1124\/jpet.111.190868","volume":"341","author":"T Mori","year":"2012","unstructured":"Mori T, Hayashi T, Su TP (2012) Compromising sigma-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-kappaB\/Bcl-2-dependent mechanism: potential relevance to Parkinson\u2019s disease. J Pharmacol Exp Ther 341(3):663\u2013671. doi: 10.1124\/jpet.111.190868","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"15_CR95","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0014-2999(85)90253-5","volume":"107","author":"AH Mulder","year":"1985","unstructured":"Mulder AH, Draper R, Sminia P, Schoffelmeer AN, Stoof JC (1985) Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro. Eur J Pharmacol 107(3):291\u2013297","journal-title":"Eur J Pharmacol"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12858-015-0040-y","volume":"16","author":"N Natsvlishvili","year":"2015","unstructured":"Natsvlishvili N, Goguadze N, Zhuravliova E, Mikeladze D (2015) Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria. BMC Biochem 16:11. doi: 10.1186\/s12858-015-0040-y","journal-title":"BMC Biochem"},{"issue":"43","key":"15_CR97","doi-asserted-by":"publisher","first-page":"18676","DOI":"10.1073\/pnas.1008911107","volume":"107","author":"G Navarro","year":"2010","unstructured":"Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortes A, Casado V, Canela EI, Ortiz J, Fuxe K, Lluis C, Ferre S, Franco R (2010) Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci U S A 107(43):18676\u201318681. doi: 10.1073\/pnas.1008911107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"15_CR98","doi-asserted-by":"publisher","first-page":"e61245","DOI":"10.1371\/journal.pone.0061245","volume":"8","author":"G Navarro","year":"2013","unstructured":"Navarro G, Moreno E, Bonaventura J, Brugarolas M, Farre D, Aguinaga D, Mallol J, Cortes A, Casado V, Lluis C, Ferre S, Franco R, Canela E, McCormick PJ (2013) Cocaine inhibits dopamine D2 receptor signaling via sigma-1-D2 receptor heteromers. PLoS One 8(4):e61245. doi: 10.1371\/journal.pone.0061245","journal-title":"PLoS One"},{"issue":"5","key":"15_CR99","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.pnpbp.2011.04.008","volume":"35","author":"K Ohi","year":"2011","unstructured":"Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Umeda-Yano S, Kamino K, Ikezawa K, Azechi M, Iwase M, Kazui H, Kasai K, Takeda M (2011) The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 35(5):1309\u20131315. doi: 10.1016\/j.pnpbp.2011.04.008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"15_CR100","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/(SICI)1096-8628(20000207)96:1<118::AID-AJMG23>3.0.CO;2-C","volume":"96","author":"O Ohmori","year":"2000","unstructured":"Ohmori O, Shinkai T, Suzuki T, Okano C, Kojima H, Terao T, Nakamura J (2000) Polymorphisms of the sigma(1) receptor gene in schizophrenia: an association study. Am J Med Genet 96(1):118\u2013122","journal-title":"Am J Med Genet"},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neulet.2013.12.005","volume":"559","author":"Y Ono","year":"2014","unstructured":"Ono Y, Tanaka H, Takata M, Nagahara Y, Noda Y, Tsuruma K, Shimazawa M, Hozumi I, Hara H (2014) SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci Lett 559:174\u2013178. doi: 10.1016\/j.neulet.2013.12.005","journal-title":"Neurosci Lett"},{"issue":"3","key":"15_CR102","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","volume":"4","author":"HT Orr","year":"1993","unstructured":"Orr HT, Chung MY, Banfi S, Kwiatkowski TJ Jr, Servadio A, Beaudet AL, McCall AE, Duvick LA, Ranum LP, Zoghbi HY (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4(3):221\u2013226. doi: 10.1038\/ng0793-221","journal-title":"Nat Genet"},{"issue":"7","key":"15_CR103","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/bph.13037","volume":"172","author":"B Oxombre","year":"2015","unstructured":"Oxombre B, Lee-Chang C, Duhamel A, Toussaint M, Giroux M, Donnier-Marechal M, Carato P, Lefranc D, Zephir H, Prin L, Melnyk P, Vermersch P (2015) High-affinity sigma1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. Br J Pharmacol 172(7):1769\u20131782. doi: 10.1111\/bph.13037","journal-title":"Br J Pharmacol"},{"issue":"34","key":"15_CR104","doi-asserted-by":"publisher","first-page":"11325","DOI":"10.1523\/JNEUROSCI.0458-14.2014","volume":"34","author":"M Pabba","year":"2014","unstructured":"Pabba M, Wong AY, Ahlskog N, Hristova E, Biscaro D, Nassrallah W, Ngsee JK, Snyder M, Beique JC, Bergeron R (2014) NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus. J Neurosci 34(34):11325\u201311338. doi: 10.1523\/jneurosci.0458-14.2014","journal-title":"J Neurosci"},{"issue":"6","key":"15_CR105","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1152\/jn.00482.2009","volume":"102","author":"A Pambo-Pambo","year":"2009","unstructured":"Pambo-Pambo A, Durand J, Gueritaud JP (2009) Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-low) mice. J Neurophysiol 102(6):3627\u20133642. doi: 10.1152\/jn.00482.2009","journal-title":"J Neurophysiol"},{"issue":"6","key":"15_CR106","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1021\/jm901689v","volume":"53","author":"F Pettersson","year":"2010","unstructured":"Pettersson F, Ponten H, Waters N, Waters S, Sonesson C (2010) Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16). J Med Chem 53(6):2510\u20132520. doi: 10.1021\/jm901689v","journal-title":"J Med Chem"},{"key":"15_CR107","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.nbd.2013.10.010","volume":"62","author":"M Peviani","year":"2014","unstructured":"Peviani M, Salvaneschi E, Bontempi L, Petese A, Manzo A, Rossi D, Salmona M, Collina S, Bigini P, Curti D (2014) Neuroprotective effects of the sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation. Neurobiol Dis 62:218\u2013232. doi: 10.1016\/j.nbd.2013.10.010","journal-title":"Neurobiol Dis"},{"issue":"3","key":"15_CR108","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1460-9568.2008.06602.x","volume":"29","author":"AH Pullen","year":"2009","unstructured":"Pullen AH, Athanasiou D (2009) Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. Eur J Neurosci 29(3):551\u2013561. doi: 10.1111\/j.1460-9568.2008.06602.x","journal-title":"Eur J Neurosci"},{"issue":"11","key":"15_CR109","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00018-010-0305-y","volume":"67","author":"S Reijonen","year":"2010","unstructured":"Reijonen S, Kukkonen JP, Hyrskyluoto A, Kivinen J, Kairisalo M, Takei N, Lindholm D, Korhonen L (2010) Downregulation of NF-kappaB signaling by mutant huntingtin proteins induces oxidative stress and cell death. Cell Mol Life Sci 67(11):1929\u20131941. doi: 10.1007\/s00018-010-0305-y","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"15_CR110","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.yexcr.2007.12.025","volume":"314","author":"S Reijonen","year":"2008","unstructured":"Reijonen S, Putkonen N, Norremolle A, Lindholm D, Korhonen L (2008) Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins. Exp Cell Res 314(5):950\u2013960. doi: 10.1016\/j.yexcr.2007.12.025","journal-title":"Exp Cell Res"},{"issue":"10","key":"15_CR111","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/mds.25559","volume":"28","author":"R Reilmann","year":"2013","unstructured":"Reilmann R (2013) The pridopidine paradox in Huntington\u2019s disease. Mov Disord 28(10):1321\u20131324. doi: 10.1002\/mds.25559","journal-title":"Mov Disord"},{"issue":"215","key":"15_CR112","doi-asserted-by":"publisher","first-page":"re1","DOI":"10.1126\/stke.2152004re1","volume":"2004","author":"R Rizzuto","year":"2004","unstructured":"Rizzuto R, Duchen MR, Pozzan T (2004) Flirting in little space: the ER\/mitochondria Ca2+ liaison. Sci STKE 2004(215):re1. doi: 10.1126\/stke.2152004re1","journal-title":"Sci STKE"},{"issue":"7","key":"15_CR113","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2174\/138161212799436601","volume":"18","author":"MJ Robson","year":"2012","unstructured":"Robson MJ, Noorbakhsh B, Seminerio MJ, Matsumoto RR (2012) Sigma-1 receptors: potential targets for the treatment of substance abuse. Curr Pharm Des 18(7):902\u2013919","journal-title":"Curr Pharm Des"},{"issue":"1","key":"15_CR114","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/mp.2012.3","volume":"18","author":"K Sahlholm","year":"2013","unstructured":"Sahlholm K, Arhem P, Fuxe K, Marcellino D (2013) The dopamine stabilizers ACR16 and (\u2212)-OSU6162 display nanomolar affinities at the sigma-1 receptor. Mol Psychiatry 18(1):12\u201314. doi: 10.1038\/mp.2012.3","journal-title":"Mol Psychiatry"},{"issue":"18","key":"15_CR115","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1007\/s00213-015-3997-8","volume":"232","author":"K Sahlholm","year":"2015","unstructured":"Sahlholm K, Sijbesma JW, Maas B, Kwizera C, Marcellino D, Ramakrishnan NK, Dierckx RA, Elsinga PH, van Waarde A (2015) Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses. Psychopharmacology (Berl) 232(18):3443\u20133453. doi: 10.1007\/s00213-015-3997-8","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"15_CR116","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1440-1819.2004.01268.x","volume":"58","author":"F Satoh","year":"2004","unstructured":"Satoh F, Miyatake R, Furukawa A, Suwaki H (2004) Lack of association between sigma receptor gene variants and schizophrenia. Psychiatry Clin Neurosci 58(4):359\u2013363. doi: 10.1111\/j.1440-1819.2004.01268.x","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"15_CR117","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ejphar.2005.06.007","volume":"518","author":"AR Schiess","year":"2005","unstructured":"Schiess AR, Partridge LD (2005) Pregnenolone sulfate acts through a G-protein-coupled sigma1-like receptor to enhance short term facilitation in adult hippocampal neurons. Eur J Pharmacol 518(1):22\u201329. doi: 10.1016\/j.ejphar.2005.06.007","journal-title":"Eur J Pharmacol"},{"key":"15_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/nature17391","author":"HR Schmidt","year":"2016","unstructured":"Schmidt HR, Zheng S, Gurpinar E, Koehl A, Manglik A, Kruse AC (2016) Crystal structure of the human sigma receptor. Nature. doi: 10.1038\/nature17391","journal-title":"Nature"},{"issue":"11","key":"15_CR119","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/ncb1104-1054","volume":"6","author":"DJ Selkoe","year":"2004","unstructured":"Selkoe DJ (2004) Cell biology of protein misfolding: the examples of Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Cell Biol 6(11):1054\u20131061. doi: 10.1038\/ncb1104-1054","journal-title":"Nat Cell Biol"},{"issue":"2","key":"15_CR120","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/jnen\/65.2.124","volume":"65","author":"B Serafini","year":"2006","unstructured":"Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Capello E, Mancardi GL, Aloisi F (2006) Dendritic cells in multiple sclerosis lesions: maturation stage, myelin uptake, and interaction with proliferating T cells. J Neuropathol Exp Neurol 65(2):124\u2013141. doi: 10.1097\/01.jnen.0000199572.96472.1c","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"15_CR121","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jnc.13695","volume":"138","author":"MA Snyder","year":"2016","unstructured":"Snyder MA, McCann K, Lalande MJ, Thivierge JP, Bergeron R (2016) Sigma receptor type 1 knockout mice show a mild deficit in plasticity but no significant change in synaptic transmission in the CA1 region of the hippocampus. J Neurochem 138(5):700\u2013709. doi: 10.1111\/jnc.13695","journal-title":"J Neurochem"},{"issue":"1","key":"15_CR122","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)38139-X","volume":"289","author":"O Soriani","year":"1999","unstructured":"Soriani O, Foll FL, Roman F, Monnet FP, Vaudry H, Cazin L (1999) A-current down-modulated by sigma receptor in frog pituitary melanotrope cells through a G protein-dependent pathway. J Pharmacol Exp Ther 289(1):321\u2013328","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"15_CR123","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1111\/jcmm.12604","volume":"19","author":"F Squitieri","year":"2015","unstructured":"Squitieri F, Di Pardo A, Favellato M, Amico E, Maglione V, Frati L (2015) Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6\/2 mouse model. J Cell Mol Med 19(11):2540\u20132548. doi: 10.1111\/jcmm.12604","journal-title":"J Cell Mol Med"},{"issue":"11","key":"15_CR124","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.it.2005.08.014","volume":"26","author":"L Steinman","year":"2005","unstructured":"Steinman L, Zamvil SS (2005) Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis. Trends Immunol 26(11):565\u2013571. doi: 10.1016\/j.it.2005.08.014","journal-title":"Trends Immunol"},{"issue":"4849","key":"15_CR125","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1126\/science.2832949","volume":"240","author":"TP Su","year":"1988","unstructured":"Su TP, London ED, Jaffe JH (1988) Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 240(4849):219\u2013221","journal-title":"Science"},{"issue":"4","key":"15_CR126","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.tips.2016.01.003","volume":"37","author":"TP Su","year":"2016","unstructured":"Su TP, Su TC, Nakamura Y, Tsai SY (2016) The sigma-1 receptor as a pluripotent modulator in living systems. Trends Pharmacol Sci 37(4):262\u2013278. doi: 10.1016\/j.tips.2016.01.003","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"15_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1750-3639.2010.00417.x","volume":"21","author":"CR Sunico","year":"2011","unstructured":"Sunico CR, Dominguez G, Garcia-Verdugo JM, Osta R, Montero F, Moreno-Lopez B (2011) Reduction in the motoneuron inhibitory\/excitatory synaptic ratio in an early-symptomatic mouse model of amyotrophic lateral sclerosis. Brain Pathol 21(1):1\u201315. doi: 10.1111\/j.1750-3639.2010.00417.x","journal-title":"Brain Pathol"},{"issue":"Suppl 1","key":"15_CR128","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson\u2019s disease. J Neurochem 139(Suppl 1):318\u2013324. doi: 10.1111\/jnc.13691","journal-title":"J Neurochem"},{"issue":"3","key":"15_CR129","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.pnpbp.2009.01.014","volume":"33","author":"R Takizawa","year":"2009","unstructured":"Takizawa R, Hashimoto K, Tochigi M, Kawakubo Y, Marumo K, Sasaki T, Fukuda M, Kasai K (2009) Association between sigma-1 receptor gene polymorphism and prefrontal hemodynamic response induced by cognitive activation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 33(3):491\u2013498. doi: 10.1016\/j.pnpbp.2009.01.014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"15_CR130","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.neuint.2011.07.006","volume":"59","author":"L Texido","year":"2011","unstructured":"Texido L, Hernandez S, Martin-Satue M, Povedano M, Casanovas A, Esquerda J, Marsal J, Solsona C (2011) Sera from amyotrophic lateral sclerosis patients induce the non-canonical activation of NMDA receptors \u201cin vitro\u201d. Neurochem Int 59(6):954\u2013964. doi: 10.1016\/j.neuint.2011.07.006","journal-title":"Neurochem Int"},{"issue":"52","key":"15_CR131","doi-asserted-by":"publisher","first-page":"22468","DOI":"10.1073\/pnas.0909089106","volume":"106","author":"SY Tsai","year":"2009","unstructured":"Tsai SY, Hayashi T, Harvey BK, Wang Y, Wu WW, Shen RF, Zhang Y, Becker KG, Hoffer BJ, Su TP (2009) Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway. Proc Natl Acad Sci U S A 106(52):22468\u201322473. doi: 10.1073\/pnas.0909089106","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR132","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-244X-3-13","volume":"3","author":"N Uchida","year":"2003","unstructured":"Uchida N, Ujike H, Nakata K, Takaki M, Nomura A, Katsu T, Tanaka Y, Imamura T, Sakai A, Kuroda S (2003) No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies. BMC Psychiatry 3:13. doi: 10.1186\/1471-244x-3-13","journal-title":"BMC Psychiatry"},{"issue":"12","key":"15_CR133","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/00019442-200512000-00005","volume":"13","author":"N Uchida","year":"2005","unstructured":"Uchida N, Ujike H, Tanaka Y, Sakai A, Yamamoto M, Fujisawa Y, Kanzaki A, Kuroda S (2005) A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease. Am J Geriatr Psychiatry 13(12):1062\u20131066. doi: 10.1176\/appi.ajgp.13.12.1062","journal-title":"Am J Geriatr Psychiatry"},{"issue":"11\u201312","key":"15_CR134","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","volume":"1762","author":"L Bosch Van Den","year":"2006","unstructured":"Van Den Bosch L, Van Damme P, Bogaert E, Robberecht W (2006) The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta 1762(11\u201312):1068\u20131082. doi: 10.1016\/j.bbadis.2006.05.002","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"15_CR135","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/npp.2008.212","volume":"34","author":"V Villard","year":"2009","unstructured":"Villard V, Espallergues J, Keller E, Alkam T, Nitta A, Yamada K, Nabeshima T, Vamvakides A, Maurice T (2009) Antiamnesic and neuroprotective effects of the aminotetrahydrofuran derivative ANAVEX1-41 against amyloid beta(25-35)-induced toxicity in mice. Neuropsychopharmacology 34(6):1552\u20131566. doi: 10.1038\/npp.2008.212","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"15_CR136","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1177\/0269881110379286","volume":"25","author":"V Villard","year":"2011","unstructured":"Villard V, Espallergues J, Keller E, Vamvakides A, Maurice T (2011) Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor\/sigma 1 (sigma1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative. J Psychopharmacol 25(8):1101\u20131117. doi: 10.1177\/0269881110379286","journal-title":"J Psychopharmacol"},{"issue":"1","key":"15_CR137","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3565(25)24245-8","volume":"244","author":"SR Wachtel","year":"1988","unstructured":"Wachtel SR, White FJ (1988) Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. J Pharmacol Exp Ther 244(1):410\u2013416","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"15_CR138","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/sj.bjp.0705117","volume":"138","author":"HH Wang","year":"2003","unstructured":"Wang HH, Chien JW, Chou YC, Liao JF, Chen CF (2003) Anti-amnesic effect of dimemorfan in mice. Br J Pharmacol 138(5):941\u2013949. doi: 10.1038\/sj.bjp.0705117","journal-title":"Br J Pharmacol"},{"issue":"2","key":"15_CR139","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neubiorev.2010.03.003","volume":"35","author":"G Yadid","year":"2010","unstructured":"Yadid G, Sudai E, Maayan R, Gispan I, Weizman A (2010) The role of dehydroepiandrosterone (DHEA) in drug-seeking behavior. Neurosci Biobehav Rev 35(2):303\u2013314. doi: 10.1016\/j.neubiorev.2010.03.003","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"15_CR140","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuropharm.2012.07.035","volume":"63","author":"R Yang","year":"2012","unstructured":"Yang R, Chen L, Wang H, Xu B, Tomimoto H, Chen L (2012) Anti-amnesic effect of neurosteroid PREGS in Abeta25-35-injected mice through sigma1 receptor- and alpha7nAChR-mediated neuroprotection. Neuropharmacology 63(6):1042\u20131050. doi: 10.1016\/j.neuropharm.2012.07.035","journal-title":"Neuropharmacology"},{"issue":"1","key":"15_CR141","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.expneurol.2009.10.019","volume":"221","author":"ZJ Yang","year":"2010","unstructured":"Yang ZJ, Carter EL, Torbey MT, Martin LJ, Koehler RC (2010) Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase\/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons. Exp Neurol 221(1):166\u2013174. doi: 10.1016\/j.expneurol.2009.10.019","journal-title":"Exp Neurol"},{"key":"15_CR142","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neuropharm.2014.09.027","volume":"89","author":"J Yin","year":"2015","unstructured":"Yin J, Sha S, Chen T, Wang C, Hong J, Jie P, Zhou R, Li L, Sokabe M, Chen L (2015) Sigma-1 (sigma(1)) receptor deficiency reduces beta-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B. Neuropharmacology 89:215\u2013224. doi: 10.1016\/j.neuropharm.2014.09.027","journal-title":"Neuropharmacology"},{"issue":"6","key":"15_CR143","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1152\/jn.2002.87.6.2867","volume":"87","author":"H Zhang","year":"2002","unstructured":"Zhang H, Cuevas J (2002) Sigma receptors inhibit high-voltage-activated calcium channels in rat sympathetic and parasympathetic neurons. J Neurophysiol 87(6):2867\u20132879","journal-title":"J Neurophysiol"},{"key":"15_CR144","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuroscience.2010.12.064","volume":"177","author":"XJ Zhang","year":"2011","unstructured":"Zhang XJ, Liu LL, Jiang SX, Zhong YM, Yang XL (2011) Activation of the zeta receptor 1 suppresses NMDA responses in rat retinal ganglion cells. Neuroscience 177:12\u201322. doi: 10.1016\/j.neuroscience.2010.12.064","journal-title":"Neuroscience"},{"issue":"1","key":"15_CR145","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ajpath.2011.03.021","volume":"179","author":"C Zussy","year":"2011","unstructured":"Zussy C, Brureau A, Delair B, Marchal S, Keller E, Ixart G, Naert G, Meunier J, Chevallier N, Maurice T, Givalois L (2011) Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid beta fragment in rats. Am J Pathol 179(1):315\u2013334. doi: 10.1016\/j.ajpath.2011.03.021","journal-title":"Am J Pathol"},{"issue":"3","key":"15_CR146","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bph.12506","volume":"171","author":"L Zvejniece","year":"2014","unstructured":"Zvejniece L, Vavers E, Svalbe B, Vilskersts R, Domracheva I, Vorona M, Veinberg G, Misane I, Stonans I, Kalvinsh I, Dambrova M (2014) The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors. Br J Pharmacol 171(3):761\u2013771. doi: 10.1111\/bph.12506","journal-title":"Br J Pharmacol"}],"container-title":["Handbook of Experimental Pharmacology","Sigma Proteins: Evolution of the Concept of Sigma Receptors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2017_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:34:22Z","timestamp":1750052062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2017_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319658513","9783319658537"],"references-count":146,"URL":"https:\/\/doi.org\/10.1007\/164_2017_15","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"9 March 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}